|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000105193 |
Summary for RPS16 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000105193 | Gene symbol | RPS16 |
| Gene name | ribosomal protein S16 | |
| HGNC | 10396 | |
| Entrez ID | 6217 | |
| Gene type | protein_coding | |
| Synonyms | RPS16|S16 | |
| UniProtAcc | P62249 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for RPS16 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for RPS16 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for RPS16 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg11374355 | chr19:39435020 | CGI:chr19:39435584-39436223 | promoter,exon,gene body | 5.01e-01 | 6.12e-01 | -3.48e+00 | 4.96e-04 | 8.36e-04 | -1.11e-01 |
| LUSC | cg11374355 | chr19:39435020 | CGI:chr19:39435584-39436223 | promoter,exon,gene body | 3.58e-01 | 5.97e-01 | -4.27e+00 | 1.94e-05 | 5.26e-04 | -2.40e-01 |
| CHOL | cg11374355 | chr19:39435020 | CGI:chr19:39435584-39436223 | promoter,exon,gene body | 3.94e-01 | 5.94e-01 | -2.80e+00 | 5.09e-03 | 1.63e-02 | -2.00e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg20641794 | chr19:39436855 | CGI:chr19:39435584-39436223 | promoter | 6.51e-01 | 5.49e-01 | 7.77e+00 | 7.72e-15 | 2.77e-14 | 1.02e-01 |
| BRCA | cg11374355 | chr19:39435020 | CGI:chr19:39435584-39436223 | promoter,exon,gene body | 3.73e-01 | 4.91e-01 | -8.88e+00 | 6.83e-19 | 3.37e-18 | -1.18e-01 |
Top |
Exon skipping events with PSI in TCGA for RPS16 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for RPS16 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for RPS16 |
| TFs related to RPS16. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | PLAGL2 | RPS16 | 3.74e+00 | 1.20e-02 | 4.89e+00 | 9.83e-01 | Female-biased |
| READ | PLAGL2 | RPS16 | 4.60e+00 | 9.89e-01 | 3.56e+00 | 4.22e-03 | Male-biased |
| READ | ZNF101 | RPS16 | 4.20e+00 | 9.81e-01 | 3.24e+00 | 5.56e-03 | Male-biased |
| SARC | PLAGL2 | RPS16 | 4.07e+00 | 9.84e-01 | 3.21e+00 | 1.76e-03 | Male-biased |
| RPS16 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for RPS16 |
| RBPs related to ES in RPS16. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | RBM8A | exon_skip_318515 | 1.17e+01 | 8.12e-03 | 1.21e+01 | 9.91e-01 | Female-biased |
| THYM | RBM4 | exon_skip_318515 | 9.68e+00 | 9.90e-01 | 9.33e+00 | 7.03e-03 | Male-biased |
| THYM | RBM8A | exon_skip_318515 | 1.24e+01 | 9.97e-01 | 1.19e+01 | 2.25e-03 | Male-biased |
| LIHC | RBM4 | exon_skip_318515 | 9.94e+00 | 9.94e-01 | 9.41e+00 | 3.36e-03 | Male-biased |
| LIHC | RBM8A | exon_skip_318515 | 1.25e+01 | 9.97e-01 | 1.19e+01 | 2.14e-03 | Male-biased |
| LUAD | RBM4 | exon_skip_318515 | 9.56e+00 | 2.97e-03 | 1.00e+01 | 9.95e-01 | Female-biased |
| LUAD | RBM8A | exon_skip_318515 | 1.22e+01 | 1.36e-03 | 1.27e+01 | 9.98e-01 | Female-biased |
| KIRP | RBM8A | exon_skip_318515 | 1.21e+01 | 4.76e-03 | 1.25e+01 | 9.95e-01 | Female-biased |
| ESCA | RBM8A | exon_skip_318515 | 1.19e+01 | 9.58e-03 | 1.23e+01 | 9.90e-01 | Female-biased |
| READ | RBM8A | exon_skip_318515 | 1.25e+01 | 1.05e-02 | 1.28e+01 | 9.89e-01 | Female-biased |
| MESO | RBM8A | exon_skip_318515 | 1.20e+01 | 2.32e-03 | 1.25e+01 | 9.97e-01 | Female-biased |
| LGG | RBM4 | exon_skip_318515 | 9.55e+00 | 1.53e-02 | 9.85e+00 | 9.83e-01 | Female-biased |
| LGG | RBM8A | exon_skip_318515 | 1.21e+01 | 1.95e-03 | 1.26e+01 | 9.98e-01 | Female-biased |
| KIRC | RBM4 | exon_skip_318515 | 9.77e+00 | 8.34e-03 | 1.01e+01 | 9.90e-01 | Female-biased |
| KIRC | RBM8A | exon_skip_318515 | 1.24e+01 | 1.59e-03 | 1.29e+01 | 9.98e-01 | Female-biased |
| BLCA | RBM4 | exon_skip_318515 | 9.29e+00 | 5.76e-03 | 9.70e+00 | 9.92e-01 | Female-biased |
| BLCA | RBM8A | exon_skip_318515 | 1.19e+01 | 5.06e-03 | 1.24e+01 | 9.94e-01 | Female-biased |
| RPS16 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1972723 | chr19:48054483:G:T | - | -0.174857718429562 | 0.0353150949153055 | READ | Female-baised eQTL |
| rs1972722 | chr19:48054486:G:T | - | -0.174857718429562 | 0.0353150949153055 | READ | Female-baised eQTL |
| rs744399 | chr19:48054746:A:C | - | -0.174857718429562 | 0.0353150949153055 | READ | Female-baised eQTL |
| rs1529479 | chr19:48055131:T:C | - | -0.174857718429562 | 0.0353150949153055 | READ | Female-baised eQTL |
| rs10412833 | chr19:42304191:C:G | - | 0.152669659393882 | 0.00155251977573937 | HNSC | Female-baised eQTL |
| rs7246789 | chr19:42306394:T:C | - | 0.152669659393882 | 0.00155251977573937 | HNSC | Female-baised eQTL |
| rs1206009 | chr19:42316378:A:G | - | 0.152669659393882 | 0.00155251977573937 | HNSC | Female-baised eQTL |
| rs1676220 | chr19:42326931:T:C | - | 0.152669659393882 | 0.00155251977573937 | HNSC | Female-baised eQTL |
| rs1676221 | chr19:42328209:A:G | - | 0.152669659393882 | 0.00155251977573937 | HNSC | Female-baised eQTL |
| rs13346991 | chr19:42360426:A:G | - | 0.152669659393882 | 0.00155251977573937 | HNSC | Female-baised eQTL |
| rs1676217 | chr19:42306029:A:G | - | 0.152641944538896 | 0.00158251507895892 | HNSC | Female-baised eQTL |
| rs1206035 | chr19:42337631:T:C | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs7255956 | chr19:42338450:A:C | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs7260287 | chr19:42338642:T:G | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs862228 | chr19:42341242:T:C | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs865436 | chr19:42342599:G:T | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs1206044 | chr19:42344663:T:C | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs1206042 | chr19:42346101:T:C | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs1676211 | chr19:42348328:G:A | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs1206029 | chr19:42349849:T:G | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs1206027 | chr19:42353293:A:G | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs1206041 | chr19:42357141:G:A | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs1206040 | chr19:42357700:A:G | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs1206038 | chr19:42358883:A:G | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs1613100 | chr19:42363395:G:T | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs1676215 | chr19:42365272:T:C | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs1654623 | chr19:42365404:T:G | - | 0.138875350087414 | 0.00672159586740463 | HNSC | Female-baised eQTL |
| rs1676213 | chr19:42363917:T:C | - | 0.138417512807207 | 0.00725309456306671 | HNSC | Female-baised eQTL |
| rs185434905 | chr19:40086134:T:G | - | 0.129908064248202 | 0.0107251438274924 | HNSC | Female-baised eQTL |
| rs62105841 | chr19:29705085:C:T | - | 0.101513464809607 | 0.0153891662563352 | HNSC | Female-baised eQTL |
| rs62105838 | chr19:29699194:G:T | - | 0.101208425150684 | 0.0159841566346692 | HNSC | Female-baised eQTL |
| rs62105840 | chr19:29701567:C:T | - | 0.101208425150684 | 0.0159841566346692 | HNSC | Female-baised eQTL |
| rs137952348 | chr19:29703482:G:A | - | 0.101208425150684 | 0.0159841566346692 | HNSC | Female-baised eQTL |
| rs851296 | chr19:42372142:T:C | - | 0.131805701384915 | 0.018182494940874 | HNSC | Female-baised eQTL |
| rs62105835 | chr19:29697634:C:T | - | 0.100123862785623 | 0.0189100441300194 | HNSC | Female-baised eQTL |
| rs62105836 | chr19:29697755:C:T | - | 0.100123862785623 | 0.0189100441300194 | HNSC | Female-baised eQTL |
| rs79337477 | chr19:29698804:A:T | - | 0.100123862785623 | 0.0189100441300194 | HNSC | Female-baised eQTL |
| rs17304618 | chr19:35379534:A:G | - | 0.124735650600369 | 0.0264971598462619 | HNSC | Female-baised eQTL |
| rs8106032 | chr19:40080794:A:C | - | 0.103832132227554 | 0.0454485432729355 | HNSC | Female-baised eQTL |
| rs851294 | chr19:42373240:G:A | - | 0.119807063848846 | 0.0470481595291957 | HNSC | Female-baised eQTL |
| rs57569766 | chr19:41723244:G:A | - | 0.271827896503739 | 0.0013591866056365 | KIRP | Female-baised eQTL |
| rs2239509 | chr19:36120359:C:T | - | 0.168848443400004 | 0.0252822321938198 | LIHC | Female-baised eQTL |
| rs241950 | chr19:37778493:C:G | - | 0.090469913249425 | 0.00477844640683337 | KIRC | Female-baised eQTL |
| rs856304 | chr19:37770270:G:A | - | 0.0866265028537504 | 0.00664764642424184 | KIRC | Female-baised eQTL |
| rs171376 | chr19:37776353:C:T | - | 0.0866265028537504 | 0.00664764642424184 | KIRC | Female-baised eQTL |
| rs241933 | chr19:37765477:G:A | - | 0.0856444408791972 | 0.00793909409759618 | KIRC | Female-baised eQTL |
| rs241932 | chr19:37766056:G:T | - | 0.0856444408791972 | 0.00793909409759618 | KIRC | Female-baised eQTL |
| rs11673023 | chr19:37748881:A:C | - | -0.0837170697148155 | 0.0124044647890789 | KIRC | Female-baised eQTL |
| rs12974225 | chr19:37749458:G:T | - | -0.0837170697148155 | 0.0124044647890789 | KIRC | Female-baised eQTL |
| rs1291 | chr19:37738477:G:A | - | -0.0809145127861983 | 0.0150443288191336 | KIRC | Female-baised eQTL |
| rs4803195 | chr19:37524104:G:T | - | 0.0826119954423648 | 0.0218399204676387 | KIRC | Female-baised eQTL |
| rs7255952 | chr19:37497895:A:G | - | 0.0838142728545071 | 0.0416122995822468 | KIRC | Female-baised eQTL |
| rs10048511 | chr19:37769026:G:A | - | 0.0825359533418752 | 0.0425722883080967 | KIRC | Female-baised eQTL |
| rs62108337 | chr19:37694112:G:A | - | -0.078429855495048 | 0.045153993862529 | KIRC | Female-baised eQTL |
| rs7246461 | chr19:37705680:C:G | - | -0.0782400915458662 | 0.0456254345327239 | KIRC | Female-baised eQTL |
| rs12979640 | chr19:37688255:T:C | - | -0.0782283055947229 | 0.0466530333184258 | KIRC | Female-baised eQTL |
| rs10420746 | chr19:37783825:G:A | - | 0.0815136387544735 | 0.0476397111190493 | KIRC | Female-baised eQTL |
| rs6508742 | chr19:37785051:C:T | - | 0.0815136387544735 | 0.0476397111190493 | KIRC | Female-baised eQTL |
| rs9304569 | chr19:37787493:C:G | - | 0.0815136387544735 | 0.0476397111190493 | KIRC | Female-baised eQTL |
| rs10409402 | chr19:37794226:G:A | - | 0.0815136387544735 | 0.0476397111190493 | KIRC | Female-baised eQTL |
| rs10409487 | chr19:37794471:A:G | - | 0.0815136387544735 | 0.0476397111190493 | KIRC | Female-baised eQTL |
| rs11083432 | chr19:37691732:A:G | - | -0.0777439436849757 | 0.049297120017636 | KIRC | Female-baised eQTL |
| rs958305 | chr19:37698539:T:C | - | -0.0777439436849757 | 0.049297120017636 | KIRC | Female-baised eQTL |
| rs56317671 | chr19:37704004:A:G | - | -0.0777439436849757 | 0.049297120017636 | KIRC | Female-baised eQTL |
| rs3760932 | chr19:32344285:T:C | - | 0.270042896947895 | 0.0149477425320176 | BLCA | Female-baised eQTL |
| rs1633919 | chr19:35203303:A:G | - | 0.0451839958946582 | 0.0103522557036306 | LUAD | Female-baised eQTL |
| rs1633918 | chr19:35203136:A:T | - | 0.0441250337256781 | 0.0132107353364116 | LUAD | Female-baised eQTL |
| rs1633920 | chr19:35203416:A:G | - | 0.0438556754348677 | 0.0141834677670869 | LUAD | Female-baised eQTL |
| rs1687990 | chr19:35203870:A:G | - | 0.0432736635422911 | 0.0172081544641752 | LUAD | Female-baised eQTL |
| rs12609432 | chr19:46499075:A:C | - | 0.0738644876606225 | 0.0278176651332575 | LUAD | Female-baised eQTL |
| rs77480971 | chr19:46499089:T:C | - | 0.0738644876606225 | 0.0278176651332575 | LUAD | Female-baised eQTL |
| rs60477322 | chr19:48145873:C:T | - | 0.0717660192768417 | 0.0314904977465536 | LUAD | Female-baised eQTL |
| rs16980543 | chr19:46499658:C:A | - | 0.0677022888494795 | 0.0388570904670213 | LUAD | Female-baised eQTL |
| rs77640585 | chr19:46499848:C:T | - | 0.0694199021343705 | 0.0406169719034328 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs56346609 | chr19:39430280:A:C | - | 0.0733004719168361 | 0.0226182738714939 | HNSC | Male-baised eQTL |
| rs8111775 | chr19:39461212:T:C | - | 0.0678783428016141 | 0.0306137532813339 | HNSC | Male-baised eQTL |
| rs35904652 | chr19:39462156:G:T | - | 0.0678783428016141 | 0.0306137532813339 | HNSC | Male-baised eQTL |
| rs12975657 | chr19:39462378:T:C | - | 0.0678783428016141 | 0.0306137532813339 | HNSC | Male-baised eQTL |
| rs68180880 | chr19:39462900:T:C | - | 0.0678783428016141 | 0.0306137532813339 | HNSC | Male-baised eQTL |
| rs2304217 | chr19:39464893:G:A | - | 0.0677740728594185 | 0.0324441835464457 | HNSC | Male-baised eQTL |
| rs12985456 | chr19:39465606:G:A | - | 0.0677740728594185 | 0.0324441835464457 | HNSC | Male-baised eQTL |
| rs8106596 | chr19:39467206:A:G | - | 0.0677740728594185 | 0.0324441835464457 | HNSC | Male-baised eQTL |
| rs35837334 | chr19:39440741:C:G | enhancer | 0.0686443156889902 | 0.0333795182858002 | HNSC | Male-baised eQTL |
| rs66667783 | chr19:39437059:G:A | promoter | 0.0686813933648654 | 0.0370060906717377 | HNSC | Male-baised eQTL |
| rs34892537 | chr19:39456442:G:A | - | 0.0670575359659027 | 0.0407306837259612 | HNSC | Male-baised eQTL |
| rs55824805 | chr19:39448809:G:A | - | 0.0670099630392057 | 0.0440822904196499 | HNSC | Male-baised eQTL |
| rs67509161 | chr19:39449695:G:A | - | 0.0670099630392057 | 0.0440822904196499 | HNSC | Male-baised eQTL |
| rs35061477 | chr19:39463611:C:T | - | 0.0661048316071319 | 0.0499444832260103 | HNSC | Male-baised eQTL |
| rs16975124 | chr19:41276791:A:G | - | 0.0675722379787583 | 0.015873993743609 | LIHC | Male-baised eQTL |
| rs1989583 | chr19:46170754:T:C | - | -0.106319745530064 | 0.0148337225228047 | LGG | Male-baised eQTL |
| rs62103132 | chr19:34020897:C:T | - | 0.0574204898591319 | 0.014782008478886 | BLCA | Male-baised eQTL |
| rs78167885 | chr19:34017868:G:T | - | 0.0543316670572288 | 0.0246562222695591 | BLCA | Male-baised eQTL |
| rs55897610 | chr19:34023790:C:A | - | 0.0550240316741654 | 0.0249356138551521 | BLCA | Male-baised eQTL |
| rs62103104 | chr19:34005508:A:G | - | 0.0526190320110762 | 0.0328086169416463 | BLCA | Male-baised eQTL |
| rs62103105 | chr19:34009775:C:T | - | 0.0526190320110762 | 0.0328086169416463 | BLCA | Male-baised eQTL |
| rs74460433 | chr19:34012386:C:T | - | 0.0526190320110762 | 0.0328086169416463 | BLCA | Male-baised eQTL |
| rs55722288 | chr19:34016070:G:T | - | 0.0503381234205488 | 0.0334901166408047 | BLCA | Male-baised eQTL |
| rs62103100 | chr19:33992789:G:C | - | 0.0524624534301962 | 0.0340868342903841 | BLCA | Male-baised eQTL |
| rs62103102 | chr19:33994969:G:A | - | 0.0524624534301962 | 0.0340868342903841 | BLCA | Male-baised eQTL |
| rs62103103 | chr19:33995407:T:C | - | 0.0524624534301962 | 0.0340868342903841 | BLCA | Male-baised eQTL |
| rs6510408 | chr19:34014040:C:T | - | 0.048659655939106 | 0.0445334407983065 | BLCA | Male-baised eQTL |
| rs56359001 | chr19:39800446:C:T | - | 0.0838447457537565 | 0.00791367695103126 | LUAD | Male-baised eQTL |
| rs79104930 | chr19:36033677:A:G | - | 0.0899020778498131 | 0.0221903446167361 | LUAD | Male-baised eQTL |
| rs137979608 | chr19:39786727:G:A | - | 0.0792005539376523 | 0.0427849224200072 | LUAD | Male-baised eQTL |
| rs142554971 | chr19:39786728:G:A | - | 0.0792005539376523 | 0.0427849224200072 | LUAD | Male-baised eQTL |
| rs2198895 | chr19:30878287:A:G | - | 0.0590133395076128 | 0.000826493326618111 | COAD | Male-baised eQTL |
| rs4802446 | chr19:38439276:A:G | - | -0.126644121256347 | 0.00241289175447719 | COAD | Male-baised eQTL |
| rs599951 | chr19:48776883:C:T | - | 0.0459107441279688 | 0.0374272572258602 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000105193 |
| CpG Site: cg20641794 | |
| Position to Gene: promoter | |
| Male Effect: -0.320330168116226 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg20641794 | chr19:39436855 | promoter | -0.320330168116226 | 2.2625668767663e-12 | -0.43670786717295723 | 6.901275542328056e-15 | LGG |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of RPS16 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
